首页> 外文会议>International Conference and Exhibition on Pharmaceutical, Nutraceutical and Cosmeceutical Technology >Polymeric Micelles for Enhanced Solubility of Meloxicam in Oral Drug Delivery
【24h】

Polymeric Micelles for Enhanced Solubility of Meloxicam in Oral Drug Delivery

机译:聚合物胶束,用于增强美洛昔康在口服药物递送中的溶解度

获取原文
获取外文期刊封面目录资料

摘要

N-arylsuccinyl chitosan was successfully synthesized by introducing hydrophobic and hydrophilic moieties into the chitosan backbone. Incorporation efficiency of the drug-loaded micelles, particle size, in vitro cytotoxicity, and in vitro drug release were investigated. Meloxicam (MX) as a model drug was loaded into the inner core of the micelles by solvent evaporation method. The critical micelle concentration (CMC) of micelles was found to be 0.0385 mg/ml. N-arylsuccinyl chitosan micelles were able to entrap hydrophobic drug (MX) and have particle sizes in the range of 342.1- 444.2 nm. The micelles could enhance solubility of MX with high incorporation efficiency (32.72%). The cytotoxicity in Caco-2 cells to be dependent on the concentration of N-arylsuccinyl chitosan with the IC50 value of 3.23 +/- 0.08 mg/ml. Therefore, N-arylsuccinyl chitosan polymeric micelle presents interest to improve solubility of hydrophobic drug for oral drug delivery.
机译:通过将疏水性和亲水部分引入壳聚糖骨架中成功地合成了N-芳基琥珀基乙酰壳聚糖。 研究了药物负载胶束,粒度,体外细胞毒性和体外药物释放的掺入效率。 通过溶剂蒸发方法将Meloxicam(MX)作为模型药物装入胶束的内核中。 发现胶束的临界胶束浓度(CMC)为0.0385mg / ml。 N-芳基琥珀基壳聚糖胶束能够诱捕疏水药(MX)并在342.1-444.2nm的范围内具有颗粒尺寸。 胶束可以增强Mx以高掺入效率(32.72%)的溶解度。 CaCO-2细胞中的细胞毒性依赖于N-芳基琥珀基壳聚糖的浓度,IC 50值为3.23 +/- 0.08mg / ml。 因此,N-芳基琥珀基壳聚糖聚合物聚合物胶束介绍改善疏水性药物用于口服药物递送的溶解度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号